Evidence map›Paper›PMID 31629836›Full record

ArticleBehavioural brain research2020

Effects of dietary 5-methoxyindole-2-carboxylic acid on brain functional recovery after ischemic stroke.

Nathalie Sumien, Renqi Huang, Zhenglan Chen, Philip H Vann, Jessica M Wong, Wenjun Li, Shaohua Yang, Michael J Forster, Liang-Jun Yan

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Discovery of a New Polymorph of 5-Methoxy-1Molecules (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nathalie SumienDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States. Electronic address: Nathalie.Sumien@unthsc.edu.
Renqi HuangDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Zhenglan ChenDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Philip H VannDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Jessica M WongDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Wenjun LiDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Shaohua YangDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Michael J ForsterDepartment of Pharmacology & Neuroscience, Institute for Healthy Aging, UNT Health Science Center, United States.
Liang-Jun YanDepartment of Pharmaceutical Sciences, UNT System College of Pharmacy, UNT Health Science Center, United States.
University of North Texas Health Science Center · USUniversity of North Texas · US

Funding

Dietary targeting of dihydrolipoamide dehydrogenase for stroke toleranceR01NS079792 · NINDS · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI FORSTER, MICHAEL J., YAN, LIANG-JUN · 2013 to 2017
$1.3M
NINDS NIH HHS R01 NS079792
6 · The paper itself

Abstract

Stroke leads to devastating outcomes including impairments of sensorimotor and cognitive function that may be long lasting. New intervention strategies are needed to overcome the long-lasting effects of ischemic injury. Previous studies determined that treatment with 5-methoxyindole-2-carboxylic acid (MICA) conferred chemical preconditioning and neuroprotection against stroke. The purpose of the current study was to determine whether the preconditioning can lead to functional improvements after stroke (done by transient middle cerebral artery occlusion). After 4 weeks of MICA feeding, half the rats underwent ischemic injury, while the other half remained intact. After one week recovery, all the rats were tested for motor and cognitive function (rotorod and water maze). At the time of euthanasia, measurements of long-term potentiation (LTP) were performed. While stroke injury led to motor and cognitive dysfunction, MICA supplementation did not reverse these impairments. However, MICA supplementation did improve stroke-related impairments in hippocampal LTP. The dichotomy of the outcomes suggest that more studies are needed to determine optimum duration and dosage for MICA to lead to substantial motor and cognitive improvements, along with LTP change and neuroprotection.

Indexed as

AnimalsBehavior, AnimalDietary SupplementsDihydrolipoamide DehydrogenaseDisease Models, AnimalHippocampusIndolesInfarction, Middle Cerebral ArteryIschemic StrokeLong-Term PotentiationMaleMaze LearningNeuroprotective AgentsPsychomotor PerformanceRatsRats, Sprague-Dawley5-methoxyindole-2-carboxylic acidDihydrolipoamide DehydrogenaseIndolesNeuroprotective AgentsCognitionDLDHMICAPreconditioningStroke

Identifiers

PMID31629836
PMCPMC6893137
OpenAlexW2981177181

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.